Skip to content
10-Q

Quarterly Report

Regenerative Medical Technology Group Inc. RMTG

0001213900-24-069065

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 14, 2024 12.54M sh
Current Liabilities Q2 2024 · Jun 30, 2024 $26.42M
Current Liabilities Q2 2024 · Dec 31, 2023 $22.25M
Total Liabilities Q2 2024 · Jun 30, 2024 $28.88M
Total Liabilities Q2 2024 · Dec 31, 2023 $24.67M
Current Assets Q2 2024 · Jun 30, 2024 $686.57K
Current Assets Q2 2024 · Dec 31, 2023 $575K
Total Assets Q2 2024 · Jun 30, 2024 $3.05M
Total Assets Q2 2024 · Dec 31, 2023 $2.88M
Shares Diluted Q2 2024 · Jun 30, 2023 12.44M sh
Shares Diluted Q2 2024 · Jun 30, 2023 12.44M sh
Capex Q2 2024 · Jun 30, 2023 $10.21K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$399.94K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$15.68M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$13.65M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$11.98M
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.16
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.30
Eps Basic Q2 2024 · Jun 30, 2023 −$0.16
Eps Basic Q2 2024 · Jun 30, 2023 −$0.30
Net Income Q2 2024 · Jun 30, 2023 −$2.03M
Net Income Q2 2024 · Jun 30, 2023 −$3.7M
Gross Profit Q2 2024 · Jun 30, 2023 $253.82K
Gross Profit Q2 2024 · Jun 30, 2023 $790.63K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $107.54K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $356.93K
Revenue Q2 2024 · Jun 30, 2023 $361.36K
Revenue Q2 2024 · Jun 30, 2023 $1.15M